Strategies of LncRNA DLX6-AS1 on Study and Therapeutics
Accumulating evidence has revealed the vital regulatory roles of lncRNA DLX6-AS1 in various tumors at pre-transcriptional, transcriptional, and post-transcriptional levels, which makes it a potential prognosis factor and therapeutic target. In addition, the presence of lncRNA DLX6-AS1 in the exosome...
Main Authors: | Yanyan Zhao, Pei Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-06-01
|
Series: | Frontiers in Genetics |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fgene.2022.871988/full |
Similar Items
-
LncRNA HOTAIR impairs the prognosis of papillary thyroid cancer via regulating cellular malignancy and epigenetically suppressing DLX1
by: Feng-Chih Kuo, et al.
Published: (2022-12-01) -
The lncRNA DLX6-AS1/miR-16-5p axis regulates autophagy and apoptosis in non-small cell lung cancer: A Boolean model of cell death
by: Shantanu Gupta, et al.
Published: (2023-12-01) -
Down-regulated lncRNA DLX6-AS1 inhibits tumorigenesis through STAT3 signaling pathway by suppressing CADM1 promoter methylation in liver cancer stem cells
by: Dong-Mei Wu, et al.
Published: (2019-06-01) -
LncRNA & Wnt signaling in colorectal cancer
by: Zeeshan Javed, et al.
Published: (2020-07-01) -
Long noncoding RNA DLX6-AS1 promotes neuroblastoma progression by regulating miR-107/BDNF pathway
by: Huan-yu Zhang, et al.
Published: (2019-11-01)